Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus
about
Where, How, and When: Positioning Posttranslational Modification Within Type 1 Diabetes PathogenesisDistinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.Pathogenic implications of iron accumulation in multiple sclerosis.Cellular oxidative processes in relation to renal disease.Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.Assessment of the effects of glutamic acid decarboxylase antibodies and trace elements on cognitive performance in older adultsDegree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c miceExtracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?Oxidative stress, prooxidants, and antioxidants: the interplay.Hypoxia: a double-edged sword of immunity.Do post-translational beta cell protein modifications trigger type 1 diabetes?Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases.Self-antigen expression in the peripheral immune system: roles in self-tolerance and type 1 diabetes pathogenesis.Copper in Diabetes Mellitus: a Meta-Analysis and Systematic Review of Plasma and Serum Studies.Antibodies to post-translationally modified insulin in type 1 diabetes.Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.Immuno-chemistry of hydroxyl radical modified GAD-65: A possible role in experimental and human diabetes mellitus.Optimizing Multiplexed Detections of Diabetes Antibodies via Quantitative Microfluidic Droplet Array.High Neonatal Blood Iron Content Is Associated with the Risk of Childhood Type 1 Diabetes Mellitus.The Role of Iron in Type 1 Diabetes Etiology: A Systematic Review of New Evidence on a Long-Standing Mystery.An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetes.
P2860
Q26750714-7D5F6ABF-F3F4-47AF-B850-231CB7D3DDACQ30854842-AEE38A13-CEED-4AAD-A7D9-2B477FF93D89Q33909053-C61F6E29-47CA-436A-AEC5-7135FB313F74Q34049616-57A34584-1DF2-44D3-8ABF-54C739C4A02CQ36019198-D0157847-1349-4C17-A504-DD4FA91FD11FQ36209928-F1E40C27-1969-464A-BA6F-65A24FB7D7DBQ36352174-9CB7332F-6D2F-461E-9D70-4039E7FA581BQ36665835-F643CC71-ACBB-4F9C-8B9A-3A5541C925FAQ36672445-B5DAA2A0-11D1-42F3-B0D9-4F22E9656EB7Q36981806-127A233F-0242-4FB9-ABB8-4C14E79F9D47Q37577377-EDE4DFDE-103D-43B8-9861-FAFE324EEEE2Q37845226-14F09D80-553F-4830-AF3C-C5AFCBFC1E87Q38139283-84EABC81-23DB-4AC8-86E9-C82993724F7BQ38222437-2F758DFD-A4A2-4790-A31E-DDF2689ADDEDQ38230215-CEA3E243-4572-4D4E-A702-88D153FBCA19Q38992170-F82D23CA-6E43-491F-8004-6DCB4303C7DFQ40561404-BBA50D59-5021-4794-A88F-355BF23CCDABQ40998700-4F066CCE-21C3-4043-9B0B-AA94812BA6F2Q44002816-E29FF964-E81C-4352-A6F9-FBF539D18886Q44996719-FFD17C7E-B4C4-4BFE-9396-1CEA844E4167Q46284091-997F41AC-2B3F-4061-8DE3-210E2FF25CFCQ46670929-CB69B36F-9203-427C-968E-FA93E3F433B4Q47153962-BDCB2895-0DB9-4F8F-9DDF-4FEB58F3822CQ47156054-BC5E73E4-BF81-423A-8F7D-5F8D14BDCD34Q47793807-47487954-52FF-485A-8B3F-86904475FBC4Q51155258-5A4343BF-87DB-484A-90EF-AFF0AB2DB97D
P2860
Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@ast
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@en
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@nl
type
label
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@ast
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@en
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@nl
prefLabel
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@ast
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@en
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@nl
P2093
P2860
P3181
P1476
Islet glutamic acid decarboxyl ...... with type 1 diabetes mellitus
@en
P2093
P2860
P304
P3181
P356
10.1046/J.1365-2249.2001.01653.X
P407
P577
2001-11-01T00:00:00Z